Glenmark Therapeutics, Inc.

FDA Regulatory Profile

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0939-2023Class IIFamotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark TherapeutiMay 1, 2023